BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pfeifhofer-Obermair C, Tymoszuk P, Petzer V, Weiss G, Nairz M. Iron in the Tumor Microenvironment-Connecting the Dots. Front Oncol 2018;8:549. [PMID: 30534534 DOI: 10.3389/fonc.2018.00549] [Cited by in Crossref: 65] [Cited by in F6Publishing: 70] [Article Influence: 16.3] [Reference Citation Analysis]
Number Citing Articles
1 Chang MR, Rusanov DA, Arakelyan J, Alshehri M, Asaturova AV, Kireeva GS, Babak MV, Ang WH. Targeting emerging cancer hallmarks by transition metal complexes: Cancer stem cells and tumor microbiome. Part I. Coordination Chemistry Reviews 2023;477:214923. [DOI: 10.1016/j.ccr.2022.214923] [Reference Citation Analysis]
2 Wang Y, Wang D, Yang L, Zhang Y. Metabolic reprogramming in the immunosuppression of tumor-associated macrophages. Chinese Medical Journal 2022;Publish Ahead of Print. [DOI: 10.1097/cm9.0000000000002426] [Reference Citation Analysis]
3 Sudarev VV, Dolotova SM, Bukhalovich SM, Bazhenov SV, Ryzhykau YL, Uversky VN, Bondarev NA, Osipov SD, Mikhailov AE, Kuklina DD, Murugova TN, Manukhov IV, Rogachev AV, Gordeliy VI, Gushchin IY, Kuklin AI, Vlasov AV. Ferritin self-assembly, structure, function, and biotechnological applications. International Journal of Biological Macromolecules 2022. [DOI: 10.1016/j.ijbiomac.2022.10.126] [Reference Citation Analysis]
4 Zhuo S, Yang L, Chen S, Tang C, Li W, Gao Z, Feng J, Yang K. Ferroptosis: A potential opportunity for intervention of pre-metastatic niche. Front Oncol 2022;12:980620. [DOI: 10.3389/fonc.2022.980620] [Reference Citation Analysis]
5 Li C, Wu X, Zheng C, Xu S, Liu Y, Qin J, Fan X, Ye Y, Fei W. Nanotechnology-integrated ferroptosis inducers: a sharp sword against tumor drug resistance. J Mater Chem B 2022. [PMID: 36043505 DOI: 10.1039/d2tb01350a] [Reference Citation Analysis]
6 Lokesh KN, Raichur AM. Bioactive nutraceutical ligands and their efficiency to chelate elemental iron of varying dynamic oxidation states to mitigate associated clinical conditions. Crit Rev Food Sci Nutr 2022;:1-27. [PMID: 35943179 DOI: 10.1080/10408398.2022.2106936] [Reference Citation Analysis]
7 Wang D, Wu H, Yang J, Li M, Ling C, Gao Z, Lu H, Shen H, Tang Y. Loss of SLC46A1 decreases tumor iron content in hepatocellular carcinoma. Hepatol Commun 2022. [PMID: 35811443 DOI: 10.1002/hep4.2031] [Reference Citation Analysis]
8 Gu R, Xia Y, Li P, Zou D, Lu K, Ren L, Zhang H, Sun Z. Ferroptosis and its Role in Gastric Cancer. Front Cell Dev Biol 2022;10:860344. [DOI: 10.3389/fcell.2022.860344] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Yung MMH, Siu MKY, Ngan HYS, Chan DW, Chan KKL. Orchestrated Action of AMPK Activation and Combined VEGF/PD-1 Blockade with Lipid Metabolic Tunning as Multi-Target Therapeutics against Ovarian Cancers. Int J Mol Sci 2022;23:6857. [PMID: 35743298 DOI: 10.3390/ijms23126857] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Filo S, Shaharabani R, Bar Hanin D, Adam M, Ben-david E, Schoffman H, Margalit N, Habib N, Shahar T, Mezer A. Uncovering molecular iron compounds in the living human brain.. [DOI: 10.1101/2022.05.02.490254] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Liu S, Cao X, Wang D, Zhu H. Iron metabolism: State of the art in hypoxic cancer cell biology. Archives of Biochemistry and Biophysics 2022. [DOI: 10.1016/j.abb.2022.109199] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Miao H, Ren Q, Li H, Zeng M, Chen D, Xu C, Chen Y, Wen Z. Comprehensive analysis of the autophagy-dependent ferroptosis-related gene FANCD2 in lung adenocarcinoma. BMC Cancer 2022;22:225. [PMID: 35236309 DOI: 10.1186/s12885-022-09314-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
13 Kusnick J, Bruneau A, Tacke F, Hammerich L. Ferroptosis in Cancer Immunotherapy—Implications for Hepatocellular Carcinoma. Immuno 2022;2:185-217. [DOI: 10.3390/immuno2010014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Nazem A, Guiry SC, Pourfathi M, Ware JB, Anderson H, Iyer SK, Moon BF, Fan Y, Witschey WR, Rizi R, Bagley SJ, Desai A, O'Rourke DM, Brem S, Nasrallah M, Nabavizadeh A. MR susceptibility imaging for detection of tumor-associated macrophages in glioblastoma. J Neurooncol 2022. [PMID: 35043276 DOI: 10.1007/s11060-022-03947-3] [Reference Citation Analysis]
15 Huang Y, Hsu JC, Koo H, Cormode DP. Repurposing ferumoxytol: Diagnostic and therapeutic applications of an FDA-approved nanoparticle. Theranostics 2022;12:796-816. [PMID: 34976214 DOI: 10.7150/thno.67375] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 16.0] [Reference Citation Analysis]
16 Alnuwaysir RIS, Hoes MF, van Veldhuisen DJ, van der Meer P, Beverborg NG. Iron Deficiency in Heart Failure: Mechanisms and Pathophysiology. J Clin Med 2021;11:125. [PMID: 35011874 DOI: 10.3390/jcm11010125] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
17 Shen DS, Yan C, Chen KH, Li L, Qu S, Zhu XD. A Nomogram Based on Circulating CD4+ T Lymphocytes and Lactate Dehydrogenase to Predict Distant Metastasis in Patients with Nasopharyngeal Carcinoma. J Inflamm Res 2021;14:6707-18. [PMID: 34916820 DOI: 10.2147/JIR.S341897] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Xu L, Li YY, Zhang YC, Wu YX, Guo DD, Long D, Liu ZH. A Novel Ferroptosis-Related Gene Signature to Predict Prognosis in Patients with Head and Neck Squamous Cell Carcinoma. Dis Markers 2021;2021:5759927. [PMID: 34853622 DOI: 10.1155/2021/5759927] [Reference Citation Analysis]
19 Abadi B, Yazdanpanah N, Nokhodchi A, Rezaei N. Smart biomaterials to enhance the efficiency of immunotherapy in glioblastoma: State of the art and future perspectives. Adv Drug Deliv Rev 2021;179:114035. [PMID: 34740765 DOI: 10.1016/j.addr.2021.114035] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
20 Jin LY, Gu YL, Zhu Q, Li XH, Jiang GQ. The role of ferroptosis-related genes for overall survival prediction in breast cancer. J Clin Lab Anal 2021;:e24094. [PMID: 34741349 DOI: 10.1002/jcla.24094] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Böttger F, Vallés-Martí A, Cahn L, Jimenez CR. High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer. J Exp Clin Cancer Res 2021;40:343. [PMID: 34717701 DOI: 10.1186/s13046-021-02134-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 16.0] [Reference Citation Analysis]
22 Ma TL, Zhou Y, Wang C, Wang L, Chen JX, Yang HH, Zhang CY, Zhou Y, Guan CX. Targeting Ferroptosis for Lung Diseases: Exploring Novel Strategies in Ferroptosis-Associated Mechanisms. Oxid Med Cell Longev 2021;2021:1098970. [PMID: 34630843 DOI: 10.1155/2021/1098970] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Chen R, Cao J, Jiang W, Wang S, Cheng J. Upregulated Expression of CYBRD1 Predicts Poor Prognosis of Patients with Ovarian Cancer. J Oncol 2021;2021:7548406. [PMID: 34594380 DOI: 10.1155/2021/7548406] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
24 Li M, Tang Y, Wang D, Zhai X, Shen H, Zhong C, Yao M, Jin A, Zhou Z, Zhou S, Fan J, Ling CQ, Ling C. Sphingosine-1-phosphate transporter spinster homolog 2 is essential for iron-regulated metastasis of hepatocellular carcinoma. Mol Ther 2021:S1525-0016(21)00467-6. [PMID: 34547466 DOI: 10.1016/j.ymthe.2021.09.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
25 Chang I, Ohn T, Moon D, Maeng YH, Jang BG, Yoon SP. SNU-333 Cells as an Appropriate Cell Line for the Orthotopic Renal Cell Carcinoma Model. Technol Cancer Res Treat 2021;20:15330338211038487. [PMID: 34490820 DOI: 10.1177/15330338211038487] [Reference Citation Analysis]
26 Chen Z, Jiang J, Fu N, Chen L. Targetting ferroptosis for blood cell-related diseases. J Drug Target 2021;:1-15. [PMID: 34415804 DOI: 10.1080/1061186X.2021.1971237] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
27 Wang Y, Chen W, Zhu M, Xian L. Ferroptosis-Related Gene Signature and Patterns of Immune Infiltration Predict the Overall Survival in Patients With Lung Adenocarcinoma. Front Mol Biosci 2021;8:692530. [PMID: 34395526 DOI: 10.3389/fmolb.2021.692530] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
28 Zacchi P, Belmonte B, Mangogna A, Morello G, Scola L, Martorana A, Borelli V. The Ferroxidase Hephaestin in Lung Cancer: Pathological Significance and Prognostic Value. Front Oncol 2021;11:638856. [PMID: 34094919 DOI: 10.3389/fonc.2021.638856] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
29 Huang R, Dong R, Wang N, He Y, Zhu P, Wang C, Lan B, Gao Y, Sun L. Adaptive Changes Allow Targeting of Ferroptosis for Glioma Treatment. Cell Mol Neurobiol 2021. [PMID: 33893939 DOI: 10.1007/s10571-021-01092-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
30 Gao J, Zhang Z, Liu Y, Zhang Z, Wang M, Gong A, Xia L, Liao X, Wang D, Zhu H. Stearoyl-CoA Desaturase 1 Potentiates Hypoxic plus Nutrient-Deprived Pancreatic Cancer Cell Ferroptosis Resistance. Oxid Med Cell Longev 2021;2021:6629804. [PMID: 33868572 DOI: 10.1155/2021/6629804] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
31 Nnamani PO, Ugwu AA, Nnadi OH, Kenechukwu FC, Ofokansi KC, Attama AA, Lehr CM. Formulation and evaluation of transdermal nanogel for delivery of artemether. Drug Deliv Transl Res 2021;11:1655-74. [PMID: 33742415 DOI: 10.1007/s13346-021-00951-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
32 Mertens C, Schnetz M, Rehwald C, Grein S, Elwakeel E, Weigert A, Brüne B, Jung M. Iron-Bound Lipocalin-2 from Tumor-Associated Macrophages Drives Breast Cancer Progression Independent of Ferroportin. Metabolites 2021;11:180. [PMID: 33808732 DOI: 10.3390/metabo11030180] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
33 Aksan A, Farrag K, Aksan S, Schroeder O, Stein J. Flipside of the Coin: Iron Deficiency and Colorectal Cancer. Front Immunol 2021;12:635899. [PMID: 33777027 DOI: 10.3389/fimmu.2021.635899] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
34 Grzywa TM, Justyniarska M, Nowis D, Golab J. Tumor Immune Evasion Induced by Dysregulation of Erythroid Progenitor Cells Development. Cancers (Basel) 2021;13:870. [PMID: 33669537 DOI: 10.3390/cancers13040870] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]
35 Sacco A, Battaglia AM, Botta C, Aversa I, Mancuso S, Costanzo F, Biamonte F. Iron Metabolism in the Tumor Microenvironment-Implications for Anti-Cancer Immune Response. Cells 2021;10:303. [PMID: 33540645 DOI: 10.3390/cells10020303] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 25.0] [Reference Citation Analysis]
36 Plücker J, Wirsik NM, Ritter AS, Schmidt T, Weigand MA. Anaesthesia as an influence in tumour progression. Langenbecks Arch Surg 2021;406:1283-94. [PMID: 33523307 DOI: 10.1007/s00423-021-02078-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
37 Yang F, Wu Z, Dai D, Zhang L, Zhang X, Zhang X, Xu Y. The iron chelator deferoxamine decreases myeloma cell survival. J Int Med Res 2021;49:300060520987396. [PMID: 33478296 DOI: 10.1177/0300060520987396] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Reva BA, Omelchenko T, Nair SS, Tewari AK. Immune Escape in Prostate Cancer: Known and Predicted Mechanisms and Targets. Urol Clin North Am 2020;47:e9-e16. [PMID: 33446324 DOI: 10.1016/j.ucl.2020.10.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
39 Votavova H, Urbanova Z, Kundrat D, Dostalova Merkerova M, Vostry M, Hruba M, Cermak J, Belickova M. Modulation of the Immune Response by Deferasirox in Myelodysplastic Syndrome Patients. Pharmaceuticals (Basel) 2021;14:41. [PMID: 33430232 DOI: 10.3390/ph14010041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
40 Prabahar A, Shanmugam L, Jose MA, Radhakrishnan KM, Raja K. A Summary on Up-To-Date Research on Fungal Siderophores on Disease, Treatment and Pathogenicity Based on Text Mining, Bioinformatics and Experts’ Opinion. Fungal Biology 2021. [DOI: 10.1007/978-3-030-53077-8_12] [Reference Citation Analysis]
41 Ploug M, Kroijer R, Qvist N, Lindahl CH, Knudsen T. Iron deficiency in colorectal cancer patients: a cohort study on prevalence and associations. Colorectal Dis 2021;23:853-9. [PMID: 33253490 DOI: 10.1111/codi.15467] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
42 Tymoszuk P, Nairz M, Brigo N, Petzer V, Heeke S, Kircher B, Hermann-Kleiter N, Klepsch V, Theurl I, Weiss G, Pfeifhofer-Obermair C. Iron Supplementation Interferes With Immune Therapy of Murine Mammary Carcinoma by Inhibiting Anti-Tumor T Cell Function. Front Oncol 2020;10:584477. [PMID: 33344239 DOI: 10.3389/fonc.2020.584477] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
43 Osman A, Oze M, Afify SM, Hassan G, El-Ghlban S, Nawara HM, Fu X, Zahra MH, Seno A, Winer I, Salomon DS, Seno M. Tumor-associated macrophages derived from cancer stem cells. Acta Histochem 2020;122:151628. [PMID: 32992123 DOI: 10.1016/j.acthis.2020.151628] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
44 Rund D. Intravenous iron: do we adequately understand the short- and long-term risks in clinical practice? Br J Haematol 2021;193:466-80. [PMID: 33216989 DOI: 10.1111/bjh.17202] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
45 Yeoh YK, Chen Z, Wong MCS, Hui M, Yu J, Ng SC, Sung JJY, Chan FKL, Chan PKS. Southern Chinese populations harbour non-nucleatum Fusobacteria possessing homologues of the colorectal cancer-associated FadA virulence factor. Gut 2020;69:1998-2007. [PMID: 32051205 DOI: 10.1136/gutjnl-2019-319635] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 12.5] [Reference Citation Analysis]
46 Piatek M, Griffith DM, Kavanagh K. Quantitative proteomic reveals gallium maltolate induces an iron-limited stress response and reduced quorum-sensing in Pseudomonas aeruginosa. J Biol Inorg Chem 2020;25:1153-65. [DOI: 10.1007/s00775-020-01831-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
47 Shibabaw T, Teferi B, Molla MD, Ayelign B. Inflammation Mediated Hepcidin-Ferroportin Pathway and Its Therapeutic Window in Breast Cancer. Breast Cancer (Dove Med Press) 2020;12:165-80. [PMID: 33116818 DOI: 10.2147/BCTT.S276404] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
48 Reva B, Omelchenko T, Calinawan A, Nair S, Schadt E, Tewari A. Prioritization of prostate cancer to immune checkpoint therapy by ranking tumors along IFN-γ axis and identification of immune resistance mechanisms.. [DOI: 10.1101/2020.10.19.345629] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
49 Jiang M, Qiao M, Zhao C, Deng J, Li X, Zhou C. Targeting ferroptosis for cancer therapy: exploring novel strategies from its mechanisms and role in cancers. Transl Lung Cancer Res 2020;9:1569-84. [PMID: 32953528 DOI: 10.21037/tlcr-20-341] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 22.0] [Reference Citation Analysis]
50 Soetaert F, Korangath P, Serantes D, Fiering S, Ivkov R. Cancer therapy with iron oxide nanoparticles: Agents of thermal and immune therapies. Adv Drug Deliv Rev 2020;163-164:65-83. [PMID: 32603814 DOI: 10.1016/j.addr.2020.06.025] [Cited by in Crossref: 113] [Cited by in F6Publishing: 122] [Article Influence: 56.5] [Reference Citation Analysis]
51 Wu Y, Zeng Q, Qi Z, Deng T, Liu F. Recent Progresses in Cancer Nanotherapeutics Design Using Artemisinins as Free Radical Precursors. Front Chem 2020;8:472. [PMID: 32626687 DOI: 10.3389/fchem.2020.00472] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
52 Bibi K, Shah MH. Study of Essential and Toxic Metal Imbalances in the Scalp Hair of Thyroid Cancer Patients in Comparison with Healthy Donors. Biol Trace Elem Res 2021;199:500-12. [PMID: 32405688 DOI: 10.1007/s12011-020-02186-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
53 Serra M, Columbano A, Ammarah U, Mazzone M, Menga A. Understanding Metal Dynamics Between Cancer Cells and Macrophages: Competition or Synergism? Front Oncol 2020;10:646. [PMID: 32426284 DOI: 10.3389/fonc.2020.00646] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
54 Mijatović S, Savić-Radojević A, Plješa-Ercegovac M, Simić T, Nicoletti F, Maksimović-Ivanić D. The Double-Faced Role of Nitric Oxide and Reactive Oxygen Species in Solid Tumors. Antioxidants (Basel) 2020;9:E374. [PMID: 32365852 DOI: 10.3390/antiox9050374] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 18.5] [Reference Citation Analysis]
55 Moreira AC, Mesquita G, Gomes MS. Ferritin: An Inflammatory Player Keeping Iron at the Core of Pathogen-Host Interactions. Microorganisms 2020;8:E589. [PMID: 32325688 DOI: 10.3390/microorganisms8040589] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 14.0] [Reference Citation Analysis]
56 Mitra A, Andrews MC, Roh W, De Macedo MP, Hudgens CW, Carapeto F, Singh S, Reuben A, Wang F, Mao X, Song X, Wani K, Tippen S, Ng KS, Schalck A, Sakellariou-Thompson DA, Chen E, Reddy SM, Spencer CN, Wiesnoski D, Little LD, Gumbs C, Cooper ZA, Burton EM, Hwu P, Davies MA, Zhang J, Bernatchez C, Navin N, Sharma P, Allison JP, Wargo JA, Yee C, Tetzlaff MT, Hwu WJ, Lazar AJ, Futreal PA. Spatially resolved analyses link genomic and immune diversity and reveal unfavorable neutrophil activation in melanoma. Nat Commun 2020;11:1839. [PMID: 32296058 DOI: 10.1038/s41467-020-15538-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
57 Brown RAM, Richardson KL, Kabir TD, Trinder D, Ganss R, Leedman PJ. Altered Iron Metabolism and Impact in Cancer Biology, Metastasis, and Immunology. Front Oncol 2020;10:476. [PMID: 32328462 DOI: 10.3389/fonc.2020.00476] [Cited by in Crossref: 69] [Cited by in F6Publishing: 77] [Article Influence: 34.5] [Reference Citation Analysis]
58 Ye Z, Liu W, Zhuo Q, Hu Q, Liu M, Sun Q, Zhang Z, Fan G, Xu W, Ji S, Yu X, Qin Y, Xu X. Ferroptosis: Final destination for cancer? Cell Prolif 2020;53:e12761. [PMID: 32100402 DOI: 10.1111/cpr.12761] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 14.5] [Reference Citation Analysis]
59 Nesterova DS, Midya V, Zacharia BE, Proctor EA, Lee SY, Stetson LC, Lathia JD, Rubin JB, Waite KA, Berens ME, Barnholtz-Sloan JS, Connor JR. Sexually dimorphic impact of the iron-regulating gene, HFE, on survival in glioblastoma. Neurooncol Adv 2020;2:vdaa001. [PMID: 32642673 DOI: 10.1093/noajnl/vdaa001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
60 Miles LF, Coulson TG, Larsen T, Burbury KL, Story DA, Bellomo R. Associations between preoperative inflammatory hyperferritinaemia and outcomes after major abdominal surgery. Br J Anaesth 2020:S0007-0912(20)30006-4. [PMID: 32000977 DOI: 10.1016/j.bja.2020.01.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
61 Pires Celeiro S, Baltazar F, Viana-pereira M. 3D culture systems as models for solid tumors and cancer metabolism. Biomaterials for 3D Tumor Modeling 2020. [DOI: 10.1016/b978-0-12-818128-7.00006-x] [Reference Citation Analysis]
62 Zhou Z, Ni K, Deng H, Chen X. Dancing with reactive oxygen species generation and elimination in nanotheranostics for disease treatment. Adv Drug Deliv Rev 2020;158:73-90. [PMID: 32526453 DOI: 10.1016/j.addr.2020.06.006] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 23.0] [Reference Citation Analysis]
63 Ambrosone CB, Zirpoli GR, Hutson AD, McCann WE, McCann SE, Barlow WE, Kelly KM, Cannioto R, Sucheston-Campbell LE, Hershman DL, Unger JM, Moore HCF, Stewart JA, Isaacs C, Hobday TJ, Salim M, Hortobagyi GN, Gralow JR, Budd GT, Albain KS. Dietary Supplement Use During Chemotherapy and Survival Outcomes of Patients With Breast Cancer Enrolled in a Cooperative Group Clinical Trial (SWOG S0221).J Clin Oncol. 2020;38:804-814. [PMID: 31855498 DOI: 10.1200/JCO.19.01203] [Cited by in Crossref: 76] [Cited by in F6Publishing: 83] [Article Influence: 25.3] [Reference Citation Analysis]
64 Lee SY, Walter V, Zhu J, Salzberg AC, Liu DJ, Connor JR. Impact of HFE variants and sex in lung cancer. PLoS One 2019;14:e0226821. [PMID: 31856248 DOI: 10.1371/journal.pone.0226821] [Reference Citation Analysis]
65 Porter CM, Haffner MC, Kulac I, Maynard JP, Baena-Del Valle JA, Isaacs WB, Yegnasubramanian S, De Marzo AM, Sfanos KS. Lactoferrin CpG Island Hypermethylation and Decoupling of mRNA and Protein Expression in the Early Stages of Prostate Carcinogenesis. Am J Pathol 2019;189:2311-22. [PMID: 31499027 DOI: 10.1016/j.ajpath.2019.07.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
66 Mora J, Mertens C, Meier JK, Fuhrmann DC, Brüne B, Jung M. Strategies to Interfere with Tumor Metabolism through the Interplay of Innate and Adaptive Immunity. Cells 2019;8:E445. [PMID: 31083487 DOI: 10.3390/cells8050445] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
67 Čížková J, Erbanová M, Sochor J, Jindrová A, Strnadová K, Horák V. Relationship between haematological profile and progression or spontaneous regression of melanoma in the Melanoma-bearing Libechov Minipigs. Vet J 2019;249:1-9. [PMID: 31239158 DOI: 10.1016/j.tvjl.2019.04.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
68 Recalcati S, Correnti M, Gammella E, Raggi C, Invernizzi P, Cairo G. Iron Metabolism in Liver Cancer Stem Cells. Front Oncol 2019;9:149. [PMID: 30941302 DOI: 10.3389/fonc.2019.00149] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
69 Leftin A, Ben-Chetrit N, Joyce JA, Koutcher JA. Imaging endogenous macrophage iron deposits reveals a metabolic biomarker of polarized tumor macrophage infiltration and response to CSF1R breast cancer immunotherapy. Sci Rep 2019;9:857. [PMID: 30696910 DOI: 10.1038/s41598-018-37408-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
70 Jung M, Mertens C, Tomat E, Brüne B. Iron as a Central Player and Promising Target in Cancer Progression. Int J Mol Sci 2019;20:E273. [PMID: 30641920 DOI: 10.3390/ijms20020273] [Cited by in Crossref: 122] [Cited by in F6Publishing: 128] [Article Influence: 40.7] [Reference Citation Analysis]